CTIS.eu › Cities › France › Valence
Valence
France
45 total trials
18 recruiting
2024-512173-27-00
5
2019-03-21
Advanced (stage IIIB/IIIC/IV) NSCLC patients eligible for treatment wi
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
2023-505972-32-00
5
2024-02-26
locally advanced anal squamous cell carcinoma
2024-514876-41-00
9
2023-12-06
Higher-risk myelodysplastic syndromes untreated and ineligible for all
2023-503422-39-00
5
2023-10-20
Hepatocellular Carcinoma (HCC)
2022-501576-25-00
5
2023-07-07
Melanoma
2022-501217-31-00
10
2023-03-09
Hepatocellular carcinoma
2024-514502-31-00
5
2021-01-11
Prurigo Nodularis
2024-514088-25-00
5
2019-10-07
Multiple Myeloma
2024-515946-17-00
5
2019-07-22
Non Small Cell Lung Cancer
2024-513206-65-00
5
2018-08-10
resected squamous cell carcinoma of head and neck
2024-517489-41-00
5
2017-03-27
High-risk stage III colon cancer
2024-513972-16-00
5
2017-01-30
- Resected tumors of sinuses or salivary glands
- Non-operable tumors
2024-518741-21-00
4
2014-12-23
colon cancer
2023-505842-24-00
5
2024-05-07
Moderate to Severe Plaque Psoriasis
2022-501417-31-01
5
2023-08-01
melanoma
2023-509668-11-00
6
2022-06-15
Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
2024-511996-13-00
5
2022-05-11
Previously untreated, unresectable, or metastatic melanoma
2022-500395-57-00
5
2019-03-04
Resectable high-risk Locally Advanced Cutaneous Squamous Cell Carcinom
2024-515356-21-00
5
2018-04-17
Adult subject (18 years of age older) with low or intermediate-1 IPSS
2023-507271-21-00
5
2017-04-11
Follicular Lymphoma
Showing 25–45 of 45 trials